Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350299

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350299

Stem Cells Market, by Type, by Application, by Technology and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

The global stem cells market is estimated to be valued at US$ 12.9 Bn in 2023 and is expected to exhibit a CAGR of 9.1% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 12.9 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 9.10% 2030 Value Projection: US$ 23.7 Bn
Stem Cells Market - IMG1

Stem cells are the body's raw materials-cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells become either new stem cells or specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells, or bone cells. No other cell in the body has the natural ability to generate new cell types. Stem cells may one day be used to make cells and tissues for the therapy of many diseases. Examples include Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis. Stem cells are different from other cells in the body in three ways:

  • Stem cells can divide and renew itself over a long period of time
  • Stem cells are unspecialized, so it cannot do specific functions in the body
  • Stem cells have the potential to become specialized cells, such as muscle cells, blood cells, and brain cells

Market Dynamics

Increasing research and development activities conducted by researchers in science institutes are contributing to the growth of the global stem cells market. For instance, in August 2022, scientists from the Weizmann Institute of Science, a public research university in Rehovot, Israel, successfully generated living, growing mouse embryos complete with organ progenitors from stem cells alone-and they did it entirely ex utero, keeping them alive for eight days with the aid of an artificial womb that previously maintained harvested embryos until they were 11 days old.

Key features of the study:

  • This report provides an in-depth analysis of the global stem cells market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global stem cells market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., STEMCELL Technologies.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cells market.

Detailed Segmentation:

  • Global Stem Cells Market, By Type:
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • Global Stem Cells Market, By Application:
    • Regenerative Medicine
    • Drug Discovery and Development
  • Global Stem Cells Market, By Technology:
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • Global Stem Cells Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Advanced Cell Technology, Inc.
    • Angel Biotechnology Holdings PLC
    • Biotricity
    • Lineage Cell Therapeutics, Inc.
    • BrainStorm Cell Limited.
    • CIRM
    • Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company)
    • Takara Bio Inc.
    • Cellular Engineering Technologies.
    • Cytori Therapeutics Inc.
    • STEMCELL Technologies
Product Code: CMI4222

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By Technology
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Stem Cells Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Stem Cells Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Adult Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Human Embryonic Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Induced Pluripotent Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Natural Rosette Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Very Small Embryonic Like Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Stem Cells Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Stem Cells Market, By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Cell Acquisition
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cell Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cryopreservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Expansion and Sub-Culture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Stem Cells Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018- 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Advanced Cell Technology, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Angel Biotechnology Holdings PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biotricity
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Lineage Cell Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BrainStorm Cell Limited.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CIRM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Takara Bio Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cellular Engineering Technologies.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cytori Therapeutics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • STEMCELL Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!